Philippines COVID-19

The World Bank slashed its growth projection for this year, indicating an economic recovery may take longer than expected.

The Philippines president received the unapproved Chinese-made Sinopharm vaccine as COVID-19 cases continue to surge.

A new wave of COVID-19 infections has once again laid bare the shortcomings of the state's response.

As the disease ravages India, several Southeast Asian nations are also weathering record outbreaks.

The incident is the latest in a long list of alleged human rights abuses that have attended one of the world’s strictest coronavirus lockdowns.

Millions of Filipinos will spend their second straight Easter Sunday under lockdown in an effort to stop a record surge of COVID-19 infections.

New research from the Philippines suggests that with hard work, it is possible to overcome ingrained mistrust.

The country’s in-demand healthcare workers are outraged at a government proposal to send them to Europe in exchange for doses of vaccine.

The government’s mass vaccination start date is in flux, and Filipinos still harbor fears after a 2016 dengue vaccine scandal eroded public confidence in vaccinations.

In addition to supporting healthcare and low-income households, Manila has focused on propping up its agricultural sector, which employs nearly a quarter of Filipinos.

The two governments are betting that vaccines will offer an escape route from the economic and public health crisis, but many obstacles remain.

The Philippine president has ordered his security unit not to cooperate with those probing their use of an unapproved China-made vaccine.